Category:
Description:
Indications:
-
Congenital
hyperplasia, bursitis, epicondylitis, ankylosing spondylitis,
osteoarthritis
-
Systemic
lupus erythematosus, pemphigus, Stevens-Johnson syndrome,
exfoliative dermatitis, severe psoriasis, mycosis, fungoides
-
Bronchial
asthma, dermatitis, serum sickness, hypersensitivity reacitions,
iritis, keratitis
-
Ulcerative
colitis, idiopathic thrombocytopenic purpura, erythroblastopenia
Contraindications:
Precautions:
Adverse
Reactions (Side Effects):
-
sodium/fluid
retention, hypertension, hypokalemic alkalosis, loss of muscle
mass
-
aseptic
necrosis of femoral/humoral heads, tendon rupture, thin skin,
petechiae
-
menstrual
irregularities, decreased carbohydrate tolerance, glaucoma,
exophthalmos
-
pigmentation
changes, negative nitrogen balance
|
Dosage:
Administered
intravenously, intramuscularly
-
Initial
dose 100mg or 500mg, depending upon severity of the condition; may
repeat dose at intervals of 2, 4, or 6 hours as indicated by patient
response.
-
Dose
may be reduced in infants and children, but it is governed more by the
severity of the condition and response of the patient than by age or
body weight but should not be less than 25mg daily.
-
Usual
dosage does not extend past 48 to 72 hours.
-
Prophylactic
antacid therapy may be indicated to reduce likelihood of peptic
ulceration.
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|